215 related articles for article (PubMed ID: 25488163)
1. Early development of endocrine and metabolic consequences after treatment of central nervous system tumors in children.
Ramanauskienė E; Labanauskas L; Verkauskienė R; Sileikienė R
Medicina (Kaunas); 2014; 50(5):275-80. PubMed ID: 25488163
[TBL] [Abstract][Full Text] [Related]
2. Late sequela after treatment of childhood low-grade gliomas: a retrospective analysis of 69 long-term survivors treated between 1983 and 2003.
Benesch M; Lackner H; Sovinz P; Suppan E; Schwinger W; Eder HG; Dornbusch HJ; Moser A; Triebl-Roth K; Urban C
J Neurooncol; 2006 Jun; 78(2):199-205. PubMed ID: 16739030
[TBL] [Abstract][Full Text] [Related]
3. Endocrinological late effects following radiotherapy and chemotherapy of childhood brain tumours.
Schmiegelow M
Dan Med Bull; 2006 Aug; 53(3):326-41. PubMed ID: 17092452
[No Abstract] [Full Text] [Related]
4. Prevalence and Risk Factors of Early Endocrine Disorders in Childhood Brain Tumor Survivors: A Nationwide, Multicenter Study.
Clement SC; Schouten-van Meeteren AY; Boot AM; Claahsen-van der Grinten HL; Granzen B; Sen Han K; Janssens GO; Michiels EM; van Trotsenburg AS; Vandertop WP; van Vuurden DG; Kremer LC; Caron HN; van Santen HM
J Clin Oncol; 2016 Dec; 34(36):4362-4370. PubMed ID: 27998218
[TBL] [Abstract][Full Text] [Related]
5. Endocrine outcome in long-term survivors of childhood brain tumors.
Shalitin S; Gal M; Goshen Y; Cohen I; Yaniv I; Phillip M
Horm Res Paediatr; 2011; 76(2):113-22. PubMed ID: 21691048
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of centrally located low-grade glioma in children.
Terashima K; Chow K; Jones J; Ahern C; Jo E; Ellezam B; Paulino AC; Okcu MF; Su J; Adesina A; Mahajan A; Dauser R; Whitehead W; Lau C; Chintagumpala M
Cancer; 2013 Jul; 119(14):2630-8. PubMed ID: 23625612
[TBL] [Abstract][Full Text] [Related]
7. Endocrine sequelae beyond 10 years in survivors of medulloblastoma.
Uday S; Murray RD; Picton S; Chumas P; Raju M; Chandwani M; Alvi S
Clin Endocrinol (Oxf); 2015 Nov; 83(5):663-70. PubMed ID: 25952583
[TBL] [Abstract][Full Text] [Related]
8. The therapy of infantile malignant brain tumors: current status?
Kalifa C; Grill J
J Neurooncol; 2005 Dec; 75(3):279-85. PubMed ID: 16195802
[TBL] [Abstract][Full Text] [Related]
9. Endocrine complications and components of the metabolic syndrome in survivors of childhood malignant non-brain solid tumors.
Shalitin S; Laur E; Lebenthal Y; Ash S; Yaniv I; Phillip M
Horm Res Paediatr; 2014; 81(1):32-42. PubMed ID: 24246763
[TBL] [Abstract][Full Text] [Related]
10. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of early hypothalamic-pituitary damage in childhood brain tumor survivors: need for standardized follow-up programs.
Clement SC; Meeteren AY; Kremer LC; van Trotsenburg AS; Caron HN; van Santen HM
Pediatr Blood Cancer; 2014 Dec; 61(12):2285-9. PubMed ID: 25131941
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone deficiency and other endocrinopathies after childhood brain tumors: results from a close follow-up in a cohort of 242 patients.
Maciel J; Dias D; Cavaco D; Donato S; Pereira MC; Simões-Pereira J
J Endocrinol Invest; 2021 Nov; 44(11):2367-2374. PubMed ID: 33683662
[TBL] [Abstract][Full Text] [Related]
13. DIAGNOSIS OF ENDOCRINE DISEASE: Endocrine late-effects of childhood cancer and its treatments.
Chemaitilly W; Cohen LE
Eur J Endocrinol; 2017 Apr; 176(4):R183-R203. PubMed ID: 28153840
[TBL] [Abstract][Full Text] [Related]
14. Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL).
Steffens M; Beauloye V; Brichard B; Robert A; Alexopoulou O; Vermylen Ch; Maiter D
Clin Endocrinol (Oxf); 2008 Nov; 69(5):819-27. PubMed ID: 18429947
[TBL] [Abstract][Full Text] [Related]
15. Early and late endocrine effects in pediatric central nervous system diseases.
Aslan IR; Cheung CC
J Pediatr Rehabil Med; 2014; 7(4):281-94. PubMed ID: 25547881
[TBL] [Abstract][Full Text] [Related]
16. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study.
Gurney JG; Kadan-Lottick NS; Packer RJ; Neglia JP; Sklar CA; Punyko JA; Stovall M; Yasui Y; Nicholson HS; Wolden S; McNeil DE; Mertens AC; Robison LL;
Cancer; 2003 Feb; 97(3):663-73. PubMed ID: 12548609
[TBL] [Abstract][Full Text] [Related]
17. The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience.
Duffner PK; Horowitz ME; Krischer JP; Burger PC; Cohen ME; Sanford RA; Friedman HS; Kun LE
Neuro Oncol; 1999 Apr; 1(2):152-61. PubMed ID: 11554387
[No Abstract] [Full Text] [Related]
18. The incidence of late endocrine dysfunction following irradiation for childhood medulloblastoma.
Abayomi OK; Sadeghi-Nejad A
Int J Radiat Oncol Biol Phys; 1986 Jun; 12(6):945-8. PubMed ID: 3721935
[TBL] [Abstract][Full Text] [Related]
19. Hyperprolactinemia and hypothyroidism following cytotoxic therapy for central nervous system malignancies.
Constine LS; Rubin P; Woolf PD; Doane K; Lush CM
J Clin Oncol; 1987 Nov; 5(11):1841-51. PubMed ID: 3681371
[TBL] [Abstract][Full Text] [Related]
20. Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial.
Grundy RG; Wilne SH; Robinson KJ; Ironside JW; Cox T; Chong WK; Michalski A; Campbell RH; Bailey CC; Thorp N; Pizer B; Punt J; Walker DA; Ellison DW; Machin D;
Eur J Cancer; 2010 Jan; 46(1):120-33. PubMed ID: 19818598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
